Avalo Therapeutics, Inc. (AVTX) quarterly cash flow statement — complete operating, investing & financing history
Avalo Therapeutics, Inc. (AVTX) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -11.54M | -18.08M | -17.69M | -14.25M | -16.36M | -11.39M | -9.46M | -15.04M | -11.53M | -16.28M | -6.2M | -2.77M | -6.84M | -11.03M | -10.05M | -3.94M | 5.73M | -12.47M | -16.07M | -17.1M |
| Operating CF Margin % | - | - | - | -24145.76% | - | - | - | -7835.42% | -4629.32% | - | - | -484.41% | -2896.61% | -1714.77% | -2116.21% | -439.73% | 38.3% | -1207.16% | -1369.74% | -7807.76% |
| Operating CF Growth % | 29.48% | -58.7% | -87.07% | 5.3% | -41.97% | 30.05% | -52.48% | -443.89% | -68.62% | -47.68% | 38.3% | 29.8% | -219.39% | 11.58% | 37.44% | 76.96% | 135.15% | 35.01% | 12.28% | -18.94% |
| Net Income | -18.95M | -36.36M | -19.63M | -13.72M | -30.63M | -20.77M | -13.15M | -35.34M | 23.04M | 98.46M | -121.29M | -8.17M | -5.23M | -8.19M | -9.96M | -9.81M | 3.19M | -12.99M | -22.05M | -19.2M |
| Depreciation & Amortization | 18K | 17K | 17K | 16K | 59K | 134K | 135K | 68K | 34K | 33K | 34K | 43K | 41K | 41K | 33K | 35K | 34K | 30K | 67K | 295K |
| Stock-Based Compensation | 5.22M | 5.3M | 3.58M | 4.51M | 3.15M | 2.72M | 3.24M | 2.9M | 1.85M | 471K | 629K | 0 | 953K | 893K | 855K | 843K | 731K | 668K | 5.31M | 1.89M |
| Deferred Taxes | 7K | 17K | 12K | 131K | 10K | 525K | -501K | 114K | -14K | 7K | 7K | -9K | 8K | 7K | 8K | 8K | 5K | 6K | 9K | -18K |
| Other Non-Cash Items | -926K | 9.95M | -586K | -5.36M | 12.18M | 2.38M | -380K | 17.82M | -34.92M | -113.93M | 115.68M | 5.28M | 1.03M | 389K | 530K | 349K | 354K | 1.34M | 350K | 349K |
| Working Capital Changes | 3.08M | 2.99M | -1.08M | 176K | -1.15M | 3.61M | 1.2M | -612K | -1.51M | -1.33M | -1.26M | 85K | -3.64M | -4.16M | -1.52M | 4.64M | 1.41M | -1.52M | 246K | -421K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 387K | -965K | 2K | 101K | 1.4M | 38K | 813K | 1.06M | 516K | 544K | 532K | 123K | -887K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18K | 1K | 1K | 2K | 1K | 2K | 13K | -22K |
| Change in Payables | -889K | 2.99M | 219K | -337K | -1.89M | 1.69M | 398K | -1.53M | 1.16M | -262K | 470K | -342K | 37K | -4.81M | 2.68M | 1.44M | -717K | -1.59M | 388K | -198K |
| Cash from Investing | -11.23M | -329.93M | 25.5M | 2.4M | -13.26M | -70.86M | 0 | 0 | 0 | 0 | 356K | 0 | 0 | 0 | -133K | -56K | -39K | -56K | 0 | -11K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -158K | 0 | 158K | 0 | -56K | -39K | -56K | 0 | -11K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 27.67% | - | 24.57% | - | 6.25% | 0.26% | 5.42% | - | 5.02% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 356K | 0 | 0 | 0 | 25K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 418K | 106K | 197K | 10.5M | 0 | 0 | 0 | 0 | 0 | 0 | 158K | 0 | -158K | -158K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.54M | 839.41M | 1.4M | 687K | 14.37M | -469K | 0 | 67.71M | 0 | -472K | 108.61M | 1K | 10.7M | 598K | 13.75M | 82K | 0 | -14.78M | 0 | 76K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.24M | 0 | 0 | 0 | 0 | -14.81M | 0 | 0 |
| Equity Issued (Net) | 2.54M | 429.2M | 2.18M | 687K | 14.37M | 40K | 0 | 185.07M | 0 | 0 | 115.63M | 1K | 25.94M | 6.53M | 13.75M | 34K | 0 | 25K | 0 | -82K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 66K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 410.21M | -779K | 0 | -1K | -509K | 0 | -117.36M | 0 | -472K | -7.01M | 0 | 0 | -5.93M | 0 | 48K | 0 | 0 | 0 | 158K |
| Net Change in Cash | -20.23M | 491.41M | 9.21M | -11.16M | -15.26M | -82.8M | -9.46M | 52.67M | -11.53M | -16.75M | 102.77M | -2.77M | 3.86M | -10.43M | 3.56M | -3.86M | 5.69M | -27.31M | -16.07M | -17.03M |
| Free Cash Flow | -11.54M | -18.08M | -17.69M | -14.25M | -16.36M | -11.39M | -9.46M | -15.04M | -11.53M | -16.28M | -6.2M | -2.92M | -6.84M | -11.03M | -10.05M | -4M | 5.69M | -12.53M | -16.07M | -17.11M |
| FCF Margin % | - | - | - | -24145.76% | - | - | - | -7835.42% | -4629.32% | - | - | -512.08% | -2896.61% | -1714.77% | -2116.21% | -445.98% | 38.04% | -1212.58% | -1369.74% | -7812.79% |
| FCF Growth % | 29.48% | -58.7% | -87.07% | 5.3% | -41.97% | 30.05% | -52.48% | -414.5% | -68.62% | -47.68% | 38.3% | 26.83% | -220.2% | 11.98% | 37.44% | 76.65% | 134.74% | 34.72% | 12.38% | -19.02% |
| FCF per Share | -0.21 | -0.41 | -0.88 | -0.77 | -1.17 | -1.05 | -0.90 | -1.44 | -1.07 | -2.13 | -7.22 | -3.65 | -35.08 | -189.40 | -205.79 | -101.81 | 144.99 | -319.79 | -410.24 | -431.75 |
| FCF Conversion (FCF/Net Income) | 0.61x | 0.50x | 0.90x | 1.04x | 0.53x | 0.55x | 0.72x | 0.43x | -0.50x | -0.17x | 0.05x | 0.34x | 1.31x | 1.35x | 1.01x | 0.40x | 1.79x | 0.96x | 0.73x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 735K | 0 | 0 | 0 | 0 | 0 | 789K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 509K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |